0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

Intestinal Mucosal Injury - Epidemiology Forecast - 2032 - Product Thumbnail Image

Intestinal Mucosal Injury - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Post-Operative Nausea & Vomiting - Epidemiology Forecast - 2032 - Product Thumbnail Image

Post-Operative Nausea & Vomiting - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Pouchitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Pouchitis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Digestive System Fistula - Epidemiology Forecast - 2032 - Product Thumbnail Image

Digestive System Fistula - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Erosive Esophagitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Erosive Esophagitis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Gastro Intestinal Bleeding - Epidemiology Forecast - 2032 - Product Thumbnail Image

Gastro Intestinal Bleeding - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
From
EUR$3,950USDGBP
Intestinal Obstruction - Epidemiology Forecast - 2032 - Product Thumbnail Image

Intestinal Obstruction - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Mallory-Weiss Tear - Epidemiology Forecast - 2032 - Product Thumbnail Image

Mallory-Weiss Tear - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Ventral Hernia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Ventral Hernia - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Chronic Norovirus Enteritis- Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Norovirus Enteritis- Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Congenital Diarrheal Disorders - Epidemiology Forecast to 2032 - Product Thumbnail Image

Congenital Diarrheal Disorders - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Anal Fissure - Epidemiology Forecast - 2032 - Product Thumbnail Image

Anal Fissure - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Autoimmune Gastritis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Autoimmune Gastritis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Oral Mucositis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Oral Mucositis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Gastroparesis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Gastroparesis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Chronic Pancreatitis (CP)- Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Pancreatitis (CP)- Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Radiation-induced Esophagitis Epidemiology Forecast to 2032 - Product Thumbnail Image

Radiation-induced Esophagitis Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
From
EUR$2,975USDGBP
EUR$3,500USDGBP
From
EUR$2,975USDGBP
EUR$3,500USDGBP
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more